Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

A major obstacle to nanodrugs-mediated cancer therapy is their rapid uptake by the reticuloendothelial system that decreases the systemic exposure of the nanodrugs to tumors and also increases toxicities. Intralipid has been shown to reduce nano-oxaliplatin-mediated toxicity while improving bioavail...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Ju, Tsai, Chin-Yi, Cheng, Ying-Min, Nieh, Su-Wen, Yeh, Teng-Kuang, Chen, Ching- Ping, Wang, Min-Hsien, Chou, Ling-Hui, Chiu, Tai-Yu, Liu, Li, Ho, Chien, Chen, Chiung- Tong, Liu, Tsang-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028991/
https://www.ncbi.nlm.nih.gov/pubmed/32071352
http://dx.doi.org/10.1038/s41598-020-59813-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028991/
https://www.ncbi.nlm.nih.gov/pubmed/32071352
http://dx.doi.org/10.1038/s41598-020-59813-7

Ejemplares similares